Outcome After High-Dose Radioiodine Therapy for Advanced Differentiated Thyroid Carcinoma in Childhood

REFERENCES

• Monte O, Longui CA, Calliari LE, Thyroid carcinoma during childhood and adolescence. Endocrinologist 2005; 15:106–110.
   Google Scholar
• Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children—a review. J Pediatr Endocrinol Metab 1997; 10:561–568.
   PubMedGoogle Scholar
• Ringel MD, Levine MA. Current therapy for childhood thyroid cancer: optimal surgery and the legacy of King Pyrrhus. Ann Surg Oncol 2003; 10:4–6.
   Google Scholar
• Millman B, Pellitteri PK. Thyroid carcinoma in children and adolescents. Arch Otolaryngol Head Neck Surg 1995; 121:1261–1264.
   Google Scholar
• Samuel AM, Sharma SM. Differentiated thyroid carcinomas in children and adolescents. Cancer 1991; 67:2186–2190.
   Google Scholar
• The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:1–33.
   PubMed Web of Science ®Google Scholar
• Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 2005; 12: 773–803.
   Google Scholar
• Mazzaferri EL. Gonadal damage from 131 I therapy for thyroid cancer. Clin Endocrinol 2002; 57:313–314.
   Google Scholar
• Haq MS, McCready RV, Harmer CL. Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy. Nucl Med Commun 2004; 25:799–805.
   Google Scholar
• Hod N, Hagag P, Baumer M, Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment. Clin Nucl Med 2005; 30:387–390.
   Google Scholar
• Filetti S, Bidart JM, Arturi F, Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999; 141:443–457.
   Google Scholar
• Bauer AJ, Tuttle RM, Francis GL. Differentiated thyroid carcinoma of children and adolescents. Endocrinologist 2002; 12:135–142.
   Google Scholar
• Rosário PW, Barroso ÁL, Rezende LL, Frequency of nonmetastatic (physilogical) uptake on posttreatment scans in patients with differentiated thyroid carcinoma. Endocrinologist 2007; 17:78–82.
   Google Scholar
• Casara D, Rubello D, Saladini G, Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626–1631.
   Google Scholar
• Bal CS, Padhy AK, Kumar A. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone. Nucl Med Commun 2001; 22:881–887.
   PubMedGoogle Scholar
• Arici C, Erdogan O, Altunbas H, Differentiated thyroid carcinoma in children and adolescents. Horm Res 2002; 57:153–156.
   Google Scholar
• Khan MU, Nawaz MK, Saadullah M, Differentiated thyroid carcinoma in a juvenile patient. Clin Nucl Med 2008; 33:319–320.
   Google Scholar
• Pujol P, Daures JP, Nsakala N, Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996; 81:4318–4323.
   PubMed Web of Science ®Google Scholar
• Samaan NA, Schultz PN, Hickey RC, The results of various modalities of treatment of well-differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714–720.
   PubMed Web of Science ®Google Scholar
• Poth M. Thyroid cancer in children and adolescents. In: Wartofsky L, ed. Thyroid Cancer: A Comprehensive Guide to Clinical Management. Totowa, NJ: Humana Press; 2000:121–128.
   Google Scholar
• Wartofsky L. An approach to the management of patients with scan negative, thyroglobulin positive, differentiated thyroid cancer: alternative imaging procedures. In: Wartofsky L, ed. Thyroid Cancer: A Comprehensive Guide to Clinical Management. Totowa, NJ: Humana Press; 2000:251–262.
   Google Scholar
• Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998; 39:1531–1536.
   PubMedGoogle Scholar
• Rubino C, de Vathaire F, Dottorini ME, Second primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89:1638–1644.
   PubMed Web of Science ®Google Scholar
• Hyer S, Vini L, O’Connell M, Testicular dose and fertility in men following I-131 therapy for thyroid cancer. Clin Endocrinol 2002; 56:755–758.
   PubMedGoogle Scholar
• Vini L, Hyer S, Al Saadi A, Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002; 78:92–93.
   Google Scholar
• Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86:1447–1463.
   PubMed Web of Science ®Google Scholar
• Bernier MO, Leenhardt L, Hoang C, Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001; 86:1568–1573.
   PubMed Web of Science ®Google Scholar